Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Calcified Tissue International Année : 2006

Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib.

Résumé

Antiremodeling agents reduce bone loss in part through direct actions on osteoclasts. Their effects on osteoblasts and bone formation activity are less clear and may differ at sites undergoing modeling vs. remodeling. Skeletally mature intact beagles, 1-2 years old at the start of the study, were treated daily with clinically relevant doses of alendronate (0.10 or 0.20 mg/kg), risedronate (0.05 or 0.10 mg/kg), raloxifene (0.50 mg/kg), or vehicle (1 mL/kg). Dynamic bone formation parameters were histologically assessed on periosteal, endocortical/trabecular, and intracortical bone envelopes of the rib. Raloxifene significantly increased periosteal surface mineral apposition rate (MAR), a measure of osteoblast activity, compared to all other treatments (+108 to +175%, P < 0.02), while having no significant effect on MAR at either the endocortical/trabecular or intracortical envelope. Alendronate (both 0.10 and 0.20 doses) and risedronate (only the 0.10 dose) significantly (P < or = 0.05) suppressed MAR on the endocortical/trabecular envelope, while none of the bisphosphonate doses significantly altered MAR at either the periosteal or intracortical envelopes compared to vehicle. Based on these results, we conclude that (1) at clinically relevant doses the two classes of antiremodeling agents, bisphosphonates and selective estrogen receptor modulators, exert differential effects on osteoblast activity in the canine rib and (2) this effect depends on whether modeling or remodeling is the predominant mechanism of bone formation.
Fichier principal
Vignette du fichier
Allen_Follet_CTI_06_Antiremodeling_Agents_Influence_Osteoblast_Activity_Differently_in.pdf (172.03 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

inserm-00557234 , version 1 (15-06-2011)

Identifiants

Citer

Matthew R. Allen, Hélène Follet, M. Khurana, Masahico Sato, David B. Burr. Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib.. Calcified Tissue International, 2006, 79 (4), pp.255-61. ⟨10.1007/s00223-006-0031-5⟩. ⟨inserm-00557234⟩
74 Consultations
297 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More